TetraLogic Pharmaceuticals Corporation Stock Price, News & Analysis (OTCMKTS:TLOG)

$0.04 0.00 (0.00 %)
(As of 11/17/2017 02:35 PM ET)
Previous Close$0.04
Today's Range$0.04 - $0.04
52-Week Range$0.01 - $0.16
Volume108,780 shs
Average Volume30,263 shs
Market Capitalization$1.08 million
P/E RatioN/A
Dividend YieldN/A
Beta2.77

About TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

TetraLogic Pharmaceuticals Corporation logoTetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.


Industry, Sector and Symbol:
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:TLOG
  • Previous Symbol: NASDAQ:TLOG
  • CUSIP: N/A
  • Web: www.tetralogicpharma.com
Sales & Book Value:
  • Annual Sales: N/A
  • Price / Sales: N/A
  • Book Value: ($0.24) per share
  • Price / Book: -0.18
Misc:
  • Outstanding Shares: 24,470,000
 

Frequently Asked Questions for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

What is TetraLogic Pharmaceuticals Corporation's stock symbol?

TetraLogic Pharmaceuticals Corporation trades on the OTCMKTS under the ticker symbol "TLOG."

How were TetraLogic Pharmaceuticals Corporation's earnings last quarter?

TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG) issued its quarterly earnings data on Thursday, February, 26th. The biopharmaceutical company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.39) by $0.14. View TetraLogic Pharmaceuticals Corporation's Earnings History.

When will TetraLogic Pharmaceuticals Corporation make its next earnings announcement?

TetraLogic Pharmaceuticals Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 23rd 2017. View Earnings Estimates for TetraLogic Pharmaceuticals Corporation.

Who are some of TetraLogic Pharmaceuticals Corporation's key competitors?

Who are TetraLogic Pharmaceuticals Corporation's key executives?

TetraLogic Pharmaceuticals Corporation's management team includes the folowing people:

  • Andrew L. Pecora M.D., Independent Chairman of the Board

How do I buy TetraLogic Pharmaceuticals Corporation stock?

Shares of TetraLogic Pharmaceuticals Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is TetraLogic Pharmaceuticals Corporation's stock price today?

One share of TetraLogic Pharmaceuticals Corporation stock can currently be purchased for approximately $0.04.

How big of a company is TetraLogic Pharmaceuticals Corporation?

TetraLogic Pharmaceuticals Corporation has a market capitalization of $1.08 million. The biopharmaceutical company earns ($49,720,000.00) in net income (profit) each year or ($1.64) on an earnings per share basis.

How can I contact TetraLogic Pharmaceuticals Corporation?

TetraLogic Pharmaceuticals Corporation's mailing address is PO Box 1305, PAOLI, PA 19301-5305, United States. The biopharmaceutical company can be reached via phone at +1-610-8899900 or via email at [email protected]


MarketBeat Community Rating for TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about TetraLogic Pharmaceuticals Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Price Target History for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Analysts' Ratings History for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Show:
DateFirmActionRatingPrice TargetDetails
1/7/2016Roth CapitalLower Price TargetBuy$5.00 -> $1.00View Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Earnings by Quarter for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Earnings History by Quarter for TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/23/2017        
2/26/2015Q414($0.39)($0.53)$1.13 millionViewN/AView Earnings Details
11/5/2014Q314($4.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG)

Insider Ownership Percentage: 15.40%
Institutional Ownership Percentage: 0.03%
Insider Trades by Quarter for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Insider Trades by Quarter for TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/9/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell333,630$0.17$56,717.10View SEC Filing  
2/5/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell1,415,490$0.18$254,788.20View SEC Filing  
2/2/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell369,132$0.19$70,135.08View SEC Filing  
1/28/2016Lifesciences Ii L.P. ClarusMajor ShareholderSell311,930$0.28$87,340.40View SEC Filing  
7/10/2015Andrew L PecoraDirectorBuy50,000$2.68$134,000.00View SEC Filing  
7/9/2015Andrew L PecoraDirectorBuy50,000$2.40$120,000.00View SEC Filing  
7/2/2015Paul J SchmittDirectorBuy10,000$2.34$23,400.00View SEC Filing  
3/27/2015Pete A MeyersCFOBuy5,000$4.35$21,750.00View SEC Filing  
3/26/2015J Kevin BuchiCEOBuy5,000$4.23$21,150.00View SEC Filing  
1/7/2015J Kevin BuchiCEOBuy5,000$5.04$25,200.00View SEC Filing  
12/10/2014Colin Glenn BegleySVPBuy5,900$6.16$36,344.00View SEC Filing  
12/9/2014J Kevin BuchiCEOBuy5,000$6.01$30,050.00View SEC Filing  
12/4/2014Pete A MeyersCFOBuy1,034$4.94$5,107.96View SEC Filing  
12/2/2014J Kevin BuchiCEOBuy10,000$4.99$49,900.00View SEC Filing  
11/26/2014Colin Glenn BegleySVPBuy3,100$4.86$15,066.00View SEC Filing  
11/26/2014Lesley RussellCOOBuy20,000$4.90$98,000.00View SEC Filing  
11/25/2014Colin Glenn BegleySVPBuy2,000$4.85$9,700.00View SEC Filing  
11/18/2014J Kevin BuchiCEOBuy10,000$4.82$48,200.00View SEC Filing  
11/17/2014Andrew L PecoraDirectorBuy20,000$4.53$90,600.00View SEC Filing  
11/12/2014Peter A MeyersCFOBuy5,000$3.98$19,900.00View SEC Filing  
11/11/2014J Kevin BuchiCEOBuy10,000$3.93$39,300.00View SEC Filing  
11/10/2014Paul J SchmittDirectorBuy20,000$4.10$82,000.00View SEC Filing  
12/17/2013J Kevin BuchiCEOBuy285,714$7.00$1,999,998.00View SEC Filing  
12/17/2013James N WoodyDirectorBuy261,427$7.00$1,829,989.00View SEC Filing  
12/17/2013Peter A MeyersCFOBuy142,857$7.00$999,999.00View SEC Filing  
12/17/2013Ventures Vii Lp HealthcareMajor ShareholderBuy713,463$7.00$4,994,241.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)

Latest Headlines for TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG)

Source:
DateHeadline
Reviewing XOMA Corporation (XOMA) and TetraLogic Pharmaceuticals Corporation (TLOG)Reviewing XOMA Corporation (XOMA) and TetraLogic Pharmaceuticals Corporation (TLOG)
www.americanbankingnews.com - November 17 at 3:06 AM

Social Media

Financials

Chart

TetraLogic Pharmaceuticals Corporation (OTCMKTS TLOG) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.